JPWO2023169419A5 - - Google Patents
Info
- Publication number
- JPWO2023169419A5 JPWO2023169419A5 JP2024553553A JP2024553553A JPWO2023169419A5 JP WO2023169419 A5 JPWO2023169419 A5 JP WO2023169419A5 JP 2024553553 A JP2024553553 A JP 2024553553A JP 2024553553 A JP2024553553 A JP 2024553553A JP WO2023169419 A5 JPWO2023169419 A5 JP WO2023169419A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence described
- hcdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2022079943 | 2022-03-09 | ||
| CNPCT/CN2022/079943 | 2022-03-09 | ||
| CN2022122679 | 2022-09-29 | ||
| CNPCT/CN2022/122679 | 2022-09-29 | ||
| CN2023077693 | 2023-02-22 | ||
| CNPCT/CN2023/077693 | 2023-02-22 | ||
| PCT/CN2023/080090 WO2023169419A1 (en) | 2022-03-09 | 2023-03-07 | Novel anti-cd3 antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025509336A JP2025509336A (ja) | 2025-04-11 |
| JPWO2023169419A5 true JPWO2023169419A5 (https=) | 2026-03-16 |
| JP2025509336A5 JP2025509336A5 (https=) | 2026-03-16 |
Family
ID=87935966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553553A Pending JP2025509336A (ja) | 2022-03-09 | 2023-03-07 | 新規抗ｃｄ３抗体およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250223358A1 (https=) |
| EP (1) | EP4490194A1 (https=) |
| JP (1) | JP2025509336A (https=) |
| KR (1) | KR20240157737A (https=) |
| CN (1) | CN118974087A (https=) |
| AU (1) | AU2023232847A1 (https=) |
| CA (1) | CA3245580A1 (https=) |
| CO (1) | CO2024013551A2 (https=) |
| IL (1) | IL315438A (https=) |
| MX (1) | MX2024010955A (https=) |
| TW (1) | TW202348630A (https=) |
| WO (1) | WO2023169419A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4724492A1 (en) * | 2023-06-09 | 2026-04-15 | Antengene Biologics Limited | Novel antibodies targeting cd3 and another target and uses thereof |
| EP4590714A1 (en) | 2023-09-21 | 2025-07-30 | Domain Therapeutics | Anti-ccr8 monoclonal antibodies and their therapeutic use |
| EP4590715A1 (en) | 2023-09-21 | 2025-07-30 | Domain Therapeutics | Anti-ccr8 monoclonal antibodies and their therapeutic use |
| WO2025119253A1 (en) * | 2023-12-06 | 2025-06-12 | Antengene (Hangzhou) Biologics Co., Ltd. | Novel antibodies that bind to cd3 and lilrb4, and uses thereof |
| WO2025230233A1 (ko) * | 2024-05-03 | 2025-11-06 | 국민대학교산학협력단 | 인간 cd3에 특이적인 항체 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1984931B (zh) * | 2004-06-03 | 2012-11-28 | 诺维莫尼公司 | 抗-cd3抗体及其使用方法 |
| EP3352760B1 (en) * | 2015-09-21 | 2026-03-11 | Aptevo Research and Development LLC | Cd3 binding polypeptides |
| MX2019007347A (es) * | 2016-12-22 | 2019-12-05 | Daiichi Sankyo Co Ltd | Anticuerpo anti-cd3 y moleculas que comprenden el anticuerpo. |
| JP7247110B2 (ja) * | 2017-06-05 | 2023-03-28 | ヌマブ セラピューティクス アクチェンゲゼルシャフト | 新規抗ｃｄ３抗体 |
| CN110799538B (zh) * | 2017-08-28 | 2023-08-01 | 西雅图免疫公司 | 抗cd3抗体及其制备和使用方法 |
-
2023
- 2023-03-07 WO PCT/CN2023/080090 patent/WO2023169419A1/en not_active Ceased
- 2023-03-07 EP EP23765997.4A patent/EP4490194A1/en active Pending
- 2023-03-07 AU AU2023232847A patent/AU2023232847A1/en active Pending
- 2023-03-07 JP JP2024553553A patent/JP2025509336A/ja active Pending
- 2023-03-07 IL IL315438A patent/IL315438A/en unknown
- 2023-03-07 US US18/844,977 patent/US20250223358A1/en active Pending
- 2023-03-07 CA CA3245580A patent/CA3245580A1/en active Pending
- 2023-03-07 CN CN202380026169.1A patent/CN118974087A/zh active Pending
- 2023-03-07 KR KR1020247033110A patent/KR20240157737A/ko active Pending
- 2023-03-09 TW TW112108766A patent/TW202348630A/zh unknown
-
2024
- 2024-09-06 MX MX2024010955A patent/MX2024010955A/es unknown
- 2024-10-07 CO CONC2024/0013551A patent/CO2024013551A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7438958B2 (ja) | 新規な抗体分子、その調製方法及びその使用 | |
| TWI878355B (zh) | 用於癌症治療之多重專一性結合蛋白 | |
| JP6708635B2 (ja) | ＣＤ３εおよびＲＯＲ１に対する二特異性抗体 | |
| US20220411536A1 (en) | Multispecific antibody | |
| US20200062858A1 (en) | Trispecific antigen binding proteins | |
| CA3030837A1 (en) | Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor | |
| JPWO2020135201A5 (https=) | ||
| WO2023169419A1 (en) | Novel anti-cd3 antibodies and uses thereof | |
| WO2023227062A1 (en) | Novel anti-gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses thereof | |
| WO2023236891A1 (en) | Novel anti-lilrb4 antibodies and uses thereof | |
| US20250051443A1 (en) | Anti-cd3 monoclonal antibodies and therapeutic constructs | |
| WO2024041315A1 (en) | Novel anti-lilrb2 antibodies and uses thereof | |
| JPWO2023169419A5 (https=) | ||
| US20240156870A1 (en) | Anti-egfr single domain antibodies and therapeutic constructs | |
| JPWO2022212876A5 (https=) | ||
| WO2024251242A1 (en) | Novel antibodies targeting cd3 and another target and uses thereof | |
| TW202413417A (zh) | 新穎抗ｃｄ３抗體及其用途 |